- Home
- RNAC vs WALD Comparison
RNAC vs WALD Comparison
Compare RNAC & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- WALD
- Stock Information
- Founded
- RNAC 2007
- WALD 1988
- Country
- RNAC United States
- WALD United States
- Employees
- RNAC N/A
- WALD N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- WALD Package Goods/Cosmetics
- Sector
- RNAC Health Care
- WALD Consumer Discretionary
- Exchange
- RNAC Nasdaq
- WALD Nasdaq
- Market Cap
- RNAC 276.3M
- WALD 306.3M
- IPO Year
- RNAC 2016
- WALD 2021
- Fundamental
- Price
- RNAC $10.05
- WALD $1.56
- Analyst Decision
- RNAC Strong Buy
- WALD Strong Buy
- Analyst Count
- RNAC 4
- WALD 5
- Target Price
- RNAC $40.00
- WALD $4.96
- AVG Volume (30 Days)
- RNAC 48.4K
- WALD 528.0K
- Earning Date
- RNAC 08-07-2025
- WALD 11-11-2025
- Dividend Yield
- RNAC N/A
- WALD N/A
- EPS Growth
- RNAC N/A
- WALD N/A
- EPS
- RNAC N/A
- WALD N/A
- Revenue
- RNAC $1,026,000.00
- WALD $273,868,000.00
- Revenue This Year
- RNAC N/A
- WALD $10.37
- Revenue Next Year
- RNAC N/A
- WALD $14.37
- P/E Ratio
- RNAC N/A
- WALD N/A
- Revenue Growth
- RNAC N/A
- WALD 25.55
- 52 Week Low
- RNAC $8.46
- WALD $1.50
- 52 Week High
- RNAC $26.50
- WALD $4.40
- Technical
- Relative Strength Index (RSI)
- RNAC 34.71
- WALD 35.98
- Support Level
- RNAC $10.50
- WALD $1.50
- Resistance Level
- RNAC $11.80
- WALD $1.79
- Average True Range (ATR)
- RNAC 0.56
- WALD 0.16
- MACD
- RNAC -0.11
- WALD 0.00
- Stochastic Oscillator
- RNAC 0.45
- WALD 10.00
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.